Search results
Results from the WOW.Com Content Network
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry .
Jeffrey Leiden is an American physician, scientist and businessman who is the executive chairman of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts. [1] He was initially appointed to the board of directors of the company in 2009 and was CEO and president from February 2012 to March 2020. [2] [3]
Reshma Kewalramani, is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1, 2020. [1] [2] [3] She is the first female CEO of a large US biotech company. [2]
Vertex Pharmaceuticals sold the royalty it receives on hepatitis C drug Incivo to its longtime partner Janssen Pharmaceutical, a subsidiary of Johnson & Johnson , for $152 million, the company ...
Vertex Pharmaceuticals (NASDAQ: VRTX) Q3 2024 Earnings Call Nov 04, 2024, 4:30 p.m. ET. ... Vertex's CEO and president; Stuart Arbuckle, chief operating officer; and Charlie Wagner, chief ...
With Vertex Pharmaceuticals ... 39th US president and noted humanitarian, has died at age 100. News. NY Post. Climbers damaged ancient petroglyph by driving anchors into rock face, Utah authoriti
Joshua S. Boger (born April 12, 1951) is an organic chemist and the founder of Vertex Pharmaceuticals Incorporated. He is considered a pioneer in the field of structure-based rational drug design . Drugs developed include amprenavir , an HIV protease inhibitor ; telaprevir , a protease inhibitor for treatment of hepatitis C ; and Kalydeco , for ...
Following significant moves toward FDA approval for two hepatitis C agents last week -- sofosbuvir by Gilead Sciences and simeprevir by Johnson & Johnson -- competitor Vertex Pharmaceuticals is ...